TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$58.36M2010: -$53.24M2011: -$19.77M2012: -$53.55M2013: -$83.48M2014: -$68.38M2015: -$32.23M2016: -$103.02M2017: $62.97M2018: -$80.33M2019: -$72.24M2020: $129.09M2021: $402.71M2022: $202.13M2023: $281.59M2024: $444.09M2025: $316.89M$316.89M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$316.89M-28.6%
2024$444.09M+57.7%
2023$281.59M+39.3%
2022$202.13M-49.8%
2021$402.71M+212.0%
2020$129.09M+278.7%
2019-$72.24M+10.1%
2018-$80.33M-227.6%
2017$62.97M+161.1%
2016-$103.02M-219.6%
2015-$32.23M+52.9%
2014-$68.38M+18.1%
2013-$83.48M-55.9%
2012-$53.55M-170.9%
2011-$19.77M+62.9%
2010-$53.24M+8.8%
2009-$58.36M—